Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Paul D. Harker-Murray MD, PhD

Paul D. Harker-Murray MD, PhD profile photo picture

Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Oncology

Member of the Cancer Center

View Curriculum Vitae

Publications (43)

  • MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231. (Hayashi RJ, Hermiston ML, Wood BL, Teachey DT, Devidas M, Chen Z, Annett RD, Asselin BL, August K, Cho S, Dunsmore KP, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju A, Lam A, Messinger YH, Miles RR, Okada M, Patel S, Schafer ES, Schechter T, Shimano KA, Singh N, Steele A, Sulis ML, Vargas S, Winter SS, Wood C, Zweider-McKay PA, Loh ML, Hunger SP, Raetz EA, Bollard CM, Allen CE) Blood 2024 Mar 08 PMID: 38457359 SCOPUS ID: 2-s2.0-85189074370 03/08/2024    
  • Editorial: Non-cellular immunotherapies in pediatric malignancies. (Alexander S, Harker-Murray P, Hayashi RJ) Front Immunol 2024;15:1379278 PMID: 38449864 PMCID: PMC10915082 SCOPUS ID: 2-s2.0-85186552347 03/07/2024    
  • Consolidative Radio therapy in Place of Autologous Stem Cell Transplant in Patients with Low-Risk Relapsed/Refractory (R/R) Classic Hodgkin Lymphoma (cHL) Treated with Nivolumab plus Brentuximab Vedotin: CheckMate 744. (Hoppe BS, Daw S, Cole P, Hodgson D, Beishuizen A, Garnier N, Buffardi S, Mascarin M, Ebeling T, Akyol A, Crowe R, Xu Y, Drachtman R, Kelly KM, Leblanc T, Harker-Murray PD) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S1-S2 PMID: 37784262 10/03/2023    
  • Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma. (Castellino SM, Giulino-Roth L, Harker-Murray P, Kahn JM, Forlenza C, Cho S, Hoppe B, Parsons SK, Kelly KM, COG Hodgkin Lymphoma Committee) Pediatr Blood Cancer 2023 Sep;70 Suppl 6(Suppl 6):e30580 PMID: 37505794 PMCID: PMC10660893 SCOPUS ID: 2-s2.0-85166669521 07/28/2023       1 Citation
  • Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group. (Mailhot Vega RB, Harker-Murray PD, Forlenza CJ, Cole P, Kelly KM, Milgrom SA, Parikh RR, Hodgson DC, Castellino SM, Kahn J, Roberts KB, Constine LS, Hoppe BS) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2):400-403 PMID: 37116589 PMCID: PMC10655744 SCOPUS ID: 2-s2.0-85162213479 04/29/2023       1 Citation
  • A 12-year-old male with localized, pink, tender papules. (Davies OMT, Astle JM, Harker-Murray PD, Wanat KA, Carlberg VM) Pediatr Dermatol 2023 Mar;40(2):367-368 PMID: 36989164 SCOPUS ID: 2-s2.0-85151312384 03/30/2023    
  • Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma. (Forlenza CJ, Rosenzweig J, Mauguen A, Buhtoiarov I, Cuglievan B, Dave H, Deyell RJ, Flerlage JE, Franklin AK, Krajewski J, Leger KJ, Marks LJ, Norris RE, Pacheco M, Willen F, Yan AP, Harker-Murray PD, Giulino-Roth L) Blood Adv 2023 Jul 11;7(13):3225-3231 PMID: 36897253 PMCID: PMC10338202 SCOPUS ID: 2-s2.0-85166675968 03/11/2023       1 Citation
  • Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults. (Harker-Murray P, Mauz-Körholz C, Leblanc T, Mascarin M, Michel G, Cooper S, Beishuizen A, Leger KJ, Amoroso L, Buffardi S, Rigaud C, Hoppe BS, Lisano J, Francis S, Sacchi M, Cole PD, Drachtman RA, Kelly KM, Daw S) Blood 2023 Apr 27;141(17):2075-2084 PMID: 36564047 PMCID: PMC10646780 SCOPUS ID: 2-s2.0-85151234604 12/24/2022       13 Citations
  • Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. (Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA) J Clin Oncol 2022 Jul 01;40(19):2106-2118 PMID: 35271306 PMCID: PMC9242409 SCOPUS ID: 2-s2.0-85133144209 03/11/2022       45 Citations
  • Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation. (Scheuermann A, Moskop A, Hopp A, Bone K, Drendel HM, Talano J, Harker-Murray P, Astle J) J Pediatr Hematol Oncol 2022 Jul 01;44(5):268-270 PMID: 35235548 SCOPUS ID: 2-s2.0-85129146818 03/03/2022       3 Citations
  • A complex KMT2A::AFF3 fusion resulting from a three-way chromosomal rearrangement in pediatric B lymphoblastic leukemia. (Miller LJ, Leventaki V, Harker-Murray PD, Drendel HM, Bone KM) Cancer Genet 2022 Apr;262-263:43-46 PMID: 34995897 SCOPUS ID: 2-s2.0-85122276846 01/08/2022    
  • Posterior Reversible Encephalopathy Syndrome in the Setting of Asparaginase-associated Pancreatitis in 2 Pediatric Patients With Acute Leukemia. (Scheuermann A, Harker-Murray P, Pommert L) J Pediatr Hematol Oncol 2022 Apr 01;44(3):e709-e712 PMID: 34966101 SCOPUS ID: 2-s2.0-85122784847 12/31/2021    
  • A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma. (Goldman S, Barth M, Shiramizu B, Shi Q, Hochberg J, Klejmont L, Harrison L, Basso J, Chu Y, Islam H, Gerard P, Agsalda-Garcia M, Shieh T, Oesterheld J, Heym K, Kirov I, Drachtman R, Harker-Murray P, Perkins S, Miles RR, Cairo M) Leukemia 2021 Oct;35(10):2994-2997 PMID: 33941850 SCOPUS ID: 2-s2.0-85105147190 05/05/2021       7 Citations
  • Novel Therapies Potentially Available for Pediatric B-Cell Non-Hodgkin Lymphoma. (Harker-Murray PD, Pommert L, Barth MJ) J Natl Compr Canc Netw 2020 Aug;18(8):1125-1134 PMID: 32755987 SCOPUS ID: 2-s2.0-85089170249 08/07/2020       15 Citations
  • Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group. (Esbenshade AJ, Kahalley LS, Baertschiger R, Dasgupta R, Goldsmith KC, Nathan PC, Harker-Murray P, Kitko CL, Kolb EA, Murphy ES, Muscal JA, Pierson CR, Reed D, Schore R, Unguru Y, Venkatramani R, Wistinghausen B, Dhall G) Pediatr Blood Cancer 2019 Oct;66(10):e27920 PMID: 31309744 PMCID: PMC6707882 SCOPUS ID: 2-s2.0-85069914717 07/17/2019       6 Citations
  • Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group. (Esbenshade AJ, Pierson CR, Thompson AL, Reed D, Gupta A, Levy A, Kahalley LS, Harker-Murray P, Schore R, Muscal JA, Embry L, Maloney K, Horton T, Zweidler-Mckay P, Dhall G) Pediatr Blood Cancer 2018 Mar;65(3) PMID: 29193588 PMCID: PMC7773146 SCOPUS ID: 2-s2.0-85040695447 12/02/2017       6 Citations
  • Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia. (Erker C, Huppler AR, Walsh TJ, McCormick ME, Suchi M, Bhatt NS, Kehl SC, Southwood J, Harker-Murray P) J Pediatr Hematol Oncol 2018 Oct;40(7):e446-e449 PMID: 28991126 PMCID: PMC5904005 SCOPUS ID: 2-s2.0-85031495362 10/11/2017       8 Citations
  • Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. (Erker C, Harker-Murray P, Talano JA) Pediatr Clin North Am 2017 Feb;64(1):91-109 PMID: 27894453 SCOPUS ID: 2-s2.0-84998773661 11/30/2016       10 Citations
  • Emerging immunotherapy in pediatric lymphoma. (Erker C, Harker-Murray P, Burke MJ) Future Oncol 2016 Jan;12(2):257-70 PMID: 26616565 SCOPUS ID: 2-s2.0-84962769178 12/01/2015       4 Citations
  • Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma. (Harker-Murray PD, Drachtman RA, Hodgson DC, Chauvenet AR, Kelly KM, Cole PD) Pediatr Blood Cancer 2014 Apr;61(4):579-86 PMID: 24504790 SCOPUS ID: 2-s2.0-84893463251 02/08/2014       36 Citations
  • Open-label bendamustine monotherapy for pediatric patients with relapsed or refractory acute leukemia: efficacy and tolerability. (Fraser C, Brown P, Megason G, Ahn HS, Cho B, Kirov I, Frankel L, Aplenc R, Bensen-Kennedy D, Munteanu M, Weaver J, Harker-Murray P) J Pediatr Hematol Oncol 2014 May;36(4):e212-8 PMID: 24072240 PMCID: PMC4020582 SCOPUS ID: 2-s2.0-84899920098 09/28/2013       11 Citations
  • Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation. (Twombley K, Pokala H, Ardura MI, Harker-Murray P, Johnson-Welch SF, Weinberg A, Seikaly M) Pediatr Transplant 2012 Sep;16(6):E201-9 PMID: 22646132 SCOPUS ID: 2-s2.0-84864609976 06/01/2012       14 Citations
  • Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. (Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, Bina M, Panoskaltsis-Mortari A, Rubinstein P, Van Rooijen N, Golovina TN, Suhoski MM, Miller JS, Wagner JE, June CH, Riley JL, Blazar BR) Blood 2008 Oct 01;112(7):2847-57 PMID: 18645038 PMCID: PMC2556620 SCOPUS ID: 2-s2.0-53449091065 07/23/2008       128 Citations
  • Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. (Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ) Biol Blood Marrow Transplant 2008 Jun;14(6):685-92 PMID: 18489994 SCOPUS ID: 2-s2.0-43449139122 05/21/2008       21 Citations
  • Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation. (Lee AB, Harker-Murray P, Ferrieri P, Schleiss MR, Tolar J) Pediatr Blood Cancer 2008 Mar;50(3):673-6 PMID: 17588235 SCOPUS ID: 2-s2.0-38549105995 06/26/2007       29 Citations
  • Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin. (Crow SS, Sullivan VV, Aysola AE, Key NS, Harker-Murray P, Foker JE, Steiner ME) Ann Thorac Surg 2007 Apr;83(4):1547-9 PMID: 17383385 SCOPUS ID: 2-s2.0-33947320990 03/27/2007       18 Citations
  • Treatment of EBV-associated T cell post-transplant lymphoproliferative disorder with CNS involvement in a pediatric solid-organ transplant patient. (Harker-Murray PD, Dayton V, Neglia J, Tolar J) J Clin Oncol 2006 Jun 20;24(18_suppl):9040 PMID: 27954443 06/20/2006    
  • Adherence of published diabetes mellitus practice guidelines to methodologic standards of guideline development. (Sica G, Harker-Murray P, Montori VM, Smith SA, EVIDENS Groups) Endocrinol Metab Clin North Am 2002 Sep;31(3):819-28 PMID: 12227133 SCOPUS ID: 2-s2.0-0036714287 09/14/2002       4 Citations
  • Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficits. (Murray PD, McGavern DB, Pease LR, Rodriguez M) Eur J Immunol 2002 Mar;32(3):606-15 PMID: 11857334 PMCID: PMC5319413 SCOPUS ID: 2-s2.0-0036210434 02/22/2002       30 Citations
  • Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence. (Ransohoff RM, Wei T, Pavelko KD, Lee JC, Murray PD, Rodriguez M) J Virol 2002 Mar;76(5):2217-24 PMID: 11836399 PMCID: PMC153814 SCOPUS ID: 2-s2.0-0036173550 02/12/2002       43 Citations
  • Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis. (Murray PD, McGavern DB, Sathornsumetee S, Rodriguez M) Brain 2001 Jul;124(Pt 7):1403-16 PMID: 11408335 PMCID: PMC5455988 SCOPUS ID: 2-s2.0-0034956124 06/16/2001       60 Citations
  • Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis. (Murray PD, Krivacic K, Chernosky A, Wei T, Ransohoff RM, Rodriguez M) J Neurovirol 2000 May;6 Suppl 1:S44-52 PMID: 10871765 SCOPUS ID: 2-s2.0-0034034717 06/29/2000       34 Citations
  • TGF-beta 2 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis. (Drescher KM, Murray PD, Lin X, Carlino JA, Rodriguez M) J Immunol 2000 Mar 15;164(6):3207-13 PMID: 10706712 SCOPUS ID: 2-s2.0-0034653933 03/08/2000       34 Citations
  • Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. (McGavern DB, Murray PD, Rivera-Quiñones C, Schmelzer JD, Low PA, Rodriguez M) Brain 2000 Mar;123 Pt 3(Pt 3):519-31 PMID: 10686175 PMCID: PMC5444460 SCOPUS ID: 2-s2.0-0033975629 02/25/2000       116 Citations
  • Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. (McGavern DB, Murray PD, Rodriguez M) J Neurosci Res 1999 Nov 15;58(4):492-504 PMID: 10533042 PMCID: PMC5451093 SCOPUS ID: 2-s2.0-0033571378 10/26/1999       75 Citations
  • CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. (Drescher KM, Murray PD, David CS, Pease LR, Rodriguez M) Brain Pathol 1999 Jan;9(1):21-31 PMID: 9989447 PMCID: PMC8098348 SCOPUS ID: 2-s2.0-0032958517 02/16/1999       23 Citations
  • Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus. (Njenga MK, Murray PD, McGavern D, Lin X, Drescher KM, Rodriguez M) J Neuropathol Exp Neurol 1999 Jan;58(1):78-91 PMID: 10068316 PMCID: PMC5444470 SCOPUS ID: 2-s2.0-0032921436 02/12/1999       31 Citations
  • Perforin-dependent neurologic injury in a viral model of multiple sclerosis. (Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M) J Neurosci 1998 Sep 15;18(18):7306-14 PMID: 9736651 PMCID: PMC6793251 SCOPUS ID: 2-s2.0-0032530698 09/16/1998       98 Citations
  • CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. (Murray PD, Pavelko KD, Leibowitz J, Lin X, Rodriguez M) J Virol 1998 Sep;72(9):7320-9 PMID: 9696828 PMCID: PMC109956 SCOPUS ID: 2-s2.0-0031821271 08/08/1998       110 Citations
  • Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity. (Lin X, Pease LR, Murray PD, Rodriguez M) J Immunol 1998 Jun 01;160(11):5661-8 PMID: 9605173 SCOPUS ID: 2-s2.0-0032103047 05/30/1998       32 Citations
  • The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis. (Rodriguez M, Rivera-Quinones C, Murray PD, Kariuki Njenga M, Wettstein PJ, Mak T) J Neurovirol 1997 May;3 Suppl 1:S43-5 PMID: 9179791 SCOPUS ID: 2-s2.0-0030943998 05/01/1997       10 Citations
  • A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination. (Miller DJ, Njenga MK, Murray PD, Leibowitz J, Rodriguez M) Int Immunol 1996 Jan;8(1):131-41 PMID: 8671597 SCOPUS ID: 2-s2.0-0030033482 01/01/1996       29 Citations
  • Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. (Murray P, Pitt B, Webb RC) Diabetologia 1994 Jul;37(7):664-70 PMID: 7958536 SCOPUS ID: 2-s2.0-0028240327 07/01/1994       18 Citations
    • Last update: 04/18/2024